Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fipamezole for Levodopa-Induced Dyskinesia in Parkinson's Disease
NCT00559871Phase 2Completed
- Sponsor
- Juvantia
- Start
- Oct 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of fipamezole in levodopa-induced dyskinesia (LID), sponsored by Juvantia. Started Oct 2007; status: completed.
02
Drugs
fipamezole
03
Conditions
levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on NCT00559871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00559871.